CellCept (Genentech, Inc.)


Welcome to the PulseAid listing for the CellCept drug offered from Genentech, Inc.. This Antimetabolite Immunosuppressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Genentech, Inc.
NON-PROPRIETARY NAME: Mycophenolate Mofetil hydrochloride
SUBSTANCE NAME: MYCOPHENOLATE MOFETIL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antimetabolite Immunosuppressant [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1998-08-12
END MARKETING DATE: 0000-00-00


CellCept HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCellCept from Genentech, Inc.
LABELER NAME: Genentech, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/20mL)
START MARKETING DATE: 1998-08-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0004-0298_d5f5de2c-01e5-446e-82be-a1e0e6a3e953
PRODUCT NDC: 0004-0298
APPLICATION NUMBER: NDA050758

Other MYCOPHENOLATE MOFETIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Genentech, Inc.CellCept